| Lantheus Holdings, Inc | $6.5b | $99.92 | +0.1% | 328.1K | |
| AbCellera Biologics Inc. Common Shares | $4.5b | $12.01 | +2.1% | 2.7M | |
| Immunome, Inc. | $2.4b | $17.92 | -0.6% | 761.1K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.4b | $12.88 | -2.1% | 353.3K | |
| Aktis Oncology, Inc. Common stock | $1.0b | $15.73 | +0.1% | 117.1K | |
| Crescent Biopharma, Inc. Common Stock | $0.5b | $12.76 | -0.4% | 172.2K | |
| Perspective Therapeutics, Inc. | $315.1m | $1.21 | -26.1% | 9.5M | |
| Actinium Pharmaceuticals, Inc | $36.8m | $1.41 | -7.9% | 202.6K | |
| PLUS THERAPEUTICS, Inc. Common Stock | $30.1m | $3.91 | 0.0% | N/A | |
| iTonic Holdings Ltd Class A Ordinary Shares | $29.1m | $2.58 | -8.2% | 42.4K | |
| American Shared Hospital Services | $9.4m | $1.25 | -0.8% | 2.1K |